Comparison of efficacy outcomes for Carfilzomib plus Dexamethasone and Daratumumab (KdD) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) and D-Pd in relapsed or refractory Multiple Myeloma

CHARİ A., Dimopoulos M., BEKSAÇ M., LELEU X., WEİSEL K., RİCHTER J., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, United States Of America, 01 October 2021, vol.21, pp.142, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • Volume: 21
  • Country: United States Of America
  • Page Numbers: pp.142
  • Ankara University Affiliated: Yes